跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DASATINIB NEWLINE PHARMA 140 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
DASATINIB NEWLINE PHARMA 140 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
DASATINIB NEWLINE PHARMA 140 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Newline Pharma S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 14, 2021
Approval ID
b68e76ebfdab8a55
Company
Newline Pharma S.L.
Type
Standard
Approval Details
Approval Id
b68e76ebfdab8a55
Drug Cima Aemps Name
DASATINIB NEWLINE PHARMA 140 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
86019
Holder Company Name
Newline Pharma S.L.
Marketing Company Name
Newline Pharma S.L.
Authorization Date
2021-06-14
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
140 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Newline Pharma S.L.
Active Ingredients
DASATINIB
140 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 14, 2021
Approval ID
b68e76ebfdab8a55
Type
Standard
Back to CIMA-AEMPS Approvals